Study of a Phakic Implantable Collamer Lens (ICL)

Sponsor
Staar Surgical Company
Study ID
NCT07790965
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Astigmatism
  • Myopia

Eligibility Criteria

Sex
ALL
Age
21 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • Phakic Implantable Collamer Lens (ICL) — DEVICE
    Diffractive Trifocal Phakic ICL

Study Details

A prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.

Key Dates

First listed
Aug 27, 2026
Start date
Nov 30, 2026
Status verified
Aug 2026
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Participants bilaterally implanted with a phakic implantable collamer lens (ICL)
    Participants will receive a phakic implantable collamer lens (ICL) in each eye

Primary Outcome Measure

Cumulative and Persistent Adverse Events [ Time Frame: 3 Months ]

Central Contacts

Related Studies